Stericycle, Inc. (NASDAQ:SRCL – Get Rating) – Research analysts at Oppenheimer cut their Q3 2022 earnings estimates for Stericycle in a research report issued to clients and investors on Monday, August 8th. Oppenheimer analyst S. Schneeberger now anticipates that the business services provider will earn $0.56 per share for the quarter, down from their previous estimate of $0.58. The consensus estimate for Stericycle’s current full-year earnings is $2.04 per share. Oppenheimer also issued estimates for Stericycle’s Q4 2022 earnings at $0.65 EPS.
Stericycle (NASDAQ:SRCL – Get Rating) last announced its earnings results on Friday, August 5th. The business services provider reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.04. The firm had revenue of $679.80 million during the quarter, compared to analyst estimates of $678.27 million. Stericycle had a negative net margin of 3.28% and a positive return on equity of 6.22%. Stericycle’s revenue was up 1.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.67 EPS.
A number of other equities analysts have also issued reports on SRCL. Barrington Research reiterated a “market perform” rating on shares of Stericycle in a research report on Tuesday, April 19th. Berenberg Bank lowered shares of Stericycle from a “buy” rating to a “hold” rating and decreased their target price for the company from $95.00 to $46.00 in a research report on Thursday, May 12th. They noted that the move was a valuation call. Robert W. Baird cut their price target on shares of Stericycle from $72.00 to $63.00 in a report on Friday, April 29th. StockNews.com downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a report on Thursday, April 21st. Finally, TheStreet downgraded shares of Stericycle from a “c” rating to a “d+” rating in a report on Thursday, May 12th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $58.67.
Stericycle Price Performance
SRCL traded up $0.98 on Wednesday, reaching $52.26. The company had a trading volume of 444 shares, compared to its average volume of 452,809. The company has a fifty day moving average of $45.39 and a 200-day moving average of $51.63. The company has a market capitalization of $4.81 billion, a P/E ratio of -53.98, a PEG ratio of 3.10 and a beta of 1.30. The company has a current ratio of 0.96, a quick ratio of 0.92 and a debt-to-equity ratio of 0.71. Stericycle has a one year low of $40.35 and a one year high of $72.11.
Institutional Investors Weigh In On Stericycle
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Ancora Advisors LLC bought a new position in Stericycle in the first quarter worth $34,000. Quent Capital LLC acquired a new stake in shares of Stericycle in the fourth quarter valued at $33,000. EverSource Wealth Advisors LLC increased its position in Stericycle by 97.2% in the second quarter. EverSource Wealth Advisors LLC now owns 572 shares of the business services provider’s stock worth $25,000 after purchasing an additional 282 shares during the period. Covestor Ltd acquired a new stake in Stericycle in the fourth quarter worth about $43,000. Finally, First Bank & Trust increased its position in Stericycle by 13.4% in the first quarter. First Bank & Trust now owns 1,756 shares of the business services provider’s stock worth $103,000 after purchasing an additional 208 shares during the period. Institutional investors and hedge funds own 99.89% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Stericycle, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Stericycle wasn’t on the list.
While Stericycle currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here